Epitalon / Epithalon

A small sublingual AEDG study reports circadian gene-expression changes. Their clinical meaning is uncertain, and safety was not reported.

A change in a laboratory marker, a test score and everyday function are different outcomes. A statistically detectable result does not by itself tell us whether someone would notice a worthwhile difference.

Check the measured endpoint, comparison and study population. The full profile preserves effect estimates and the source's clinical-significance assessment, including when that assessment is not supplied.

The claim to test: Gene-expression changes establish rejuvenation or lifespan benefit.

What the reviewed records say:

The gap: The broader review remains incomplete. This formulation cannot establish the safety or efficacy of injected Epitalon.

Durability, effects in other populations and healthy-lifespan outcomes need their own evidence.

Independent replication, meaningful human outcomes, longer follow-up and better safety reporting would make these results easier to interpret.

The broader review remains incomplete. This formulation cannot establish the safety or efficacy of injected Epitalon.